Research Department, The Infectious Diseases Institute Limited, Makerere University, Kampala, Uganda.
Department of Global Health, University of Washington, Seattle, WA.
J Acquir Immune Defic Syndr. 2024 Oct 1;97(2):125-132. doi: 10.1097/QAI.0000000000003471.
Peer-delivered HIV self-testing (HIVST) and sexually transmitted infection self-sampling (STISS) may promote adherence to oral pre-exposure prophylaxis (PrEP), but no studies have analyzed this approach among transgender women (TGW) in sub-Saharan Africa.
The Peer study was a cluster randomized trial in Uganda (October 2020-July 2022; NCT04328025).
Ten TGW peer groups, each with 1 TGW peer and 8 TGW, were randomized 1:1 to receive quarterly in-clinic HIV testing with PrEP refills as standard-of-care (SOC) or SOC plus monthly peer delivery of oral-fluid HIVST, STISS, and PrEP refills (intervention). Participants were followed for 12 months. The primary outcome was PrEP adherence.
We screened 85 TGW and enrolled 82 (41 per arm). The median age was 22 years (interquartile range [IQR] 20-24). Twelve-month retention was 88% (72/82). At the 3, 6, 9, and 12-month clinic visits, 10%, 5%, 5%, and 0% of TGW in the intervention arm had TFV-DP levels ≥700 fmol/punch, versus 7%, 15%, 7%, and 2% in the SOC arm, respectively (P = 0.18). At all visits, any detectable TFV-DP levels were significantly higher in SOC than the peer delivery group (P < 0.04). PrEP adherence was associated with sex work (incidence rate ratio 6.93; 95% CI: 2.33 to 20.60) and >10 years of schooling (incidence rate ratio 2.35; 95% CI: 1.14 to 4.84). There was a strong correlation between tenofovir detection in dried blood spots and urine (P < 0.001). No HIV seroconversions occurred.
Peer-delivered HIVST and STISS did not increase low levels of oral PrEP adherence among TGW in Uganda. Long-acting PrEP formulations should be considered for this population.
同伴提供的艾滋病毒自检(HIVST)和性传播感染自检(STISS)可能会促进口服暴露前预防(PrEP)的依从性,但在撒哈拉以南非洲的跨性别女性(TGW)中,尚无研究分析这种方法。
Peer 研究是在乌干达进行的一项集群随机试验(2020 年 10 月至 2022 年 7 月;NCT04328025)。
10 个 TGW 同伴小组,每个小组有 1 个 TGW 同伴和 8 个 TGW,按照 1:1 的比例随机分配接受每季度在诊所进行的 HIV 检测和 PrEP 补充作为标准护理(SOC)或 SOC 加每月由同伴提供的口服液 HIVST、STISS 和 PrEP 补充(干预)。参与者随访 12 个月。主要结局是 PrEP 依从性。
我们共筛查了 85 名 TGW 并招募了 82 名(每组 41 名)。中位年龄为 22 岁(四分位间距 [IQR] 20-24)。12 个月的保留率为 88%(72/82)。在第 3、6、9 和 12 个月的诊所就诊时,干预组中有 10%、5%、5%和 0%的 TGW 的 TFV-DP 水平≥700fmol/点,而 SOC 组分别为 7%、15%、7%和 2%(P=0.18)。在所有就诊时,SOC 组的任何可检测 TFV-DP 水平均明显高于同伴提供组(P<0.04)。PrEP 依从性与性工作(发病率比 6.93;95%CI:2.33 至 20.60)和>10 年受教育年限(发病率比 2.35;95%CI:1.14 至 4.84)相关。在干血斑和尿液中检测到的替诺福韦之间存在很强的相关性(P<0.001)。未发生 HIV 血清转换。
在乌干达,同伴提供的 HIVST 和 STISS 并未增加 TGW 中低水平的口服 PrEP 依从性。应考虑为该人群提供长效 PrEP 制剂。